Figure 2From: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohortY-axis represents the proportion that achieved target serum urate (sUA) in each group, febuxostat versus allopurinol. a provides the comparison for treatment-naive new users and b includes both treatment-naive or not-naive populations (i.e., new and current users).Back to article page